FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1497014525> ?p ?o ?g. }

• W1497014525 endingPage "12787" @default.
• W1497014525 startingPage "12769" @default.
• W1497014525 abstract "// Raphael Berges 1 , Nathalie Baeza-Kallee 1 , Emeline Tabouret 1, 2 , Olivier Chinot 1, 2 , Marie Petit 1, 2 , Anna Kruczynski 3 , Dominique Figarella-Branger 1, 2 , Stephane Honore 1, 2 , Diane Braguer 1, 2 1 Aix-Marseille Université, INSERM, CRO2 UMR_S 911, Marseille 13385, France 2 APHM, CHU Timone, Marseille 13385, France 3 Centre de Recherche d'Oncologie Expérimentale, Institut de Recherche Pierre Fabre, Toulouse, France Correspondence to: Diane Braguer, e-mail: diane.braguer@univ-amu.fr Keywords: glioblastoma, EB1, biomarker, Vinca -alkaloid, microtubules Received: July 03, 2014      Accepted: October 26, 2014      Published: November 28, 2014 ABSTRACT End-binding 1 protein (EB1) is a key player in the regulation of microtubule (MT) dynamics. Here, we investigated the role of EB1 in glioblastoma (GBM) tumor progression and its potential predictive role for response to Vinca -alkaloid chemotherapy. Immunohistological analysis of the 109 human GBM cases revealed that EB1 overexpression correlated with poor outcome including progression-free survival and overall survival. Downregulation of EB1 by shRNA inhibited cell migration and proliferation in vitro . Conversely, EB1 overexpression promoted them and accelerated tumor growth in orthotopically-transplanted nude mice. Furthermore, EB1 was largely overexpressed in stem-like GBM6 that display in vivo a higher tumorigenicity with a more infiltrative pattern of migration than stem-like GBM9. GBM6 showed strong and EB1-dependent migratory potential. The predictive role of EB1 in the response of GBM cells to chemotherapy was investigated. Vinflunine and vincristine increased survival of EB1-overexpressing U87 bearing mice and were more effective to inhibit cell migration and proliferation in EB1-overexpressing clones than in controls. Vinca inhibited the increase of MT growth rate and growth length induced by EB1 overexpression. Altogether, our results show that EB1 expression level has a prognostic value in GBM, and that Vinca -alkaloid chemotherapy could improve the treatment of GBM patients with EB1-overexpressing tumor." @default.
• W1497014525 created "2016-06-24" @default.
• W1497014525 creator A5000418022 @default.
• W1497014525 creator A5021199881 @default.
• W1497014525 creator A5041653118 @default.
• W1497014525 creator A5044960963 @default.
• W1497014525 creator A5047274558 @default.
• W1497014525 creator A5047450286 @default.
• W1497014525 creator A5057836479 @default.
• W1497014525 creator A5059620448 @default.
• W1497014525 creator A5075387803 @default.
• W1497014525 date "2014-11-28" @default.
• W1497014525 modified "2023-10-17" @default.
• W1497014525 title "End-binding 1 protein overexpression correlates with glioblastoma progression and sensitizes to<i>Vinca</i>-alkaloids<i>in vitro</i>and<i>in vivo</i>" @default.
• W1497014525 cites W1522441529 @default.
• W1497014525 cites W1682346320 @default.
• W1497014525 cites W1915728046 @default.
• W1497014525 cites W1959628099 @default.
• W1497014525 cites W1968475526 @default.
• W1497014525 cites W1973935352 @default.
• W1497014525 cites W1979702150 @default.
• W1497014525 cites W1981414879 @default.
• W1497014525 cites W1984374880 @default.
• W1497014525 cites W1985249910 @default.
• W1497014525 cites W1987210221 @default.
• W1497014525 cites W1998684576 @default.
• W1497014525 cites W2009612742 @default.
• W1497014525 cites W2015787260 @default.
• W1497014525 cites W2022450135 @default.
• W1497014525 cites W2025504334 @default.
• W1497014525 cites W2026682681 @default.
• W1497014525 cites W2027542963 @default.
• W1497014525 cites W2030916076 @default.
• W1497014525 cites W2035528204 @default.
• W1497014525 cites W2040158067 @default.
• W1497014525 cites W2040679153 @default.
• W1497014525 cites W2040827479 @default.
• W1497014525 cites W2047080266 @default.
• W1497014525 cites W2052756081 @default.
• W1497014525 cites W2054084181 @default.
• W1497014525 cites W2058108824 @default.
• W1497014525 cites W2058844863 @default.
• W1497014525 cites W2059624809 @default.
• W1497014525 cites W2075812441 @default.
• W1497014525 cites W2076706169 @default.
• W1497014525 cites W2087963727 @default.
• W1497014525 cites W2095999479 @default.
• W1497014525 cites W2096287682 @default.
• W1497014525 cites W2108772496 @default.
• W1497014525 cites W2110909153 @default.
• W1497014525 cites W2113101214 @default.
• W1497014525 cites W2118132761 @default.
• W1497014525 cites W2124139519 @default.
• W1497014525 cites W2129133898 @default.
• W1497014525 cites W2133865472 @default.
• W1497014525 cites W2148142505 @default.
• W1497014525 cites W2148688292 @default.
• W1497014525 cites W2152024378 @default.
• W1497014525 cites W2152110564 @default.
• W1497014525 cites W2167202847 @default.
• W1497014525 cites W2168784615 @default.
• W1497014525 cites W2410212047 @default.
• W1497014525 doi "https://doi.org/10.18632/oncotarget.2646" @default.
• W1497014525 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4350359" @default.
• W1497014525 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25473893" @default.
• W1497014525 hasPublicationYear "2014" @default.
• W1497014525 type Work @default.
• W1497014525 sameAs 1497014525 @default.
• W1497014525 citedByCount "25" @default.
• W1497014525 countsByYear W14970145252015 @default.
• W1497014525 countsByYear W14970145252016 @default.
• W1497014525 countsByYear W14970145252017 @default.
• W1497014525 countsByYear W14970145252018 @default.
• W1497014525 countsByYear W14970145252019 @default.
• W1497014525 countsByYear W14970145252020 @default.
• W1497014525 countsByYear W14970145252021 @default.
• W1497014525 countsByYear W14970145252022 @default.
• W1497014525 crossrefType "journal-article" @default.
• W1497014525 hasAuthorship W1497014525A5000418022 @default.
• W1497014525 hasAuthorship W1497014525A5021199881 @default.
• W1497014525 hasAuthorship W1497014525A5041653118 @default.
• W1497014525 hasAuthorship W1497014525A5044960963 @default.
• W1497014525 hasAuthorship W1497014525A5047274558 @default.
• W1497014525 hasAuthorship W1497014525A5047450286 @default.
• W1497014525 hasAuthorship W1497014525A5057836479 @default.
• W1497014525 hasAuthorship W1497014525A5059620448 @default.
• W1497014525 hasAuthorship W1497014525A5075387803 @default.
• W1497014525 hasBestOaLocation W14970145251 @default.
• W1497014525 hasConcept C104317684 @default.
• W1497014525 hasConcept C126322002 @default.
• W1497014525 hasConcept C127561419 @default.
• W1497014525 hasConcept C143998085 @default.
• W1497014525 hasConcept C150903083 @default.
• W1497014525 hasConcept C173396325 @default.
• W1497014525 hasConcept C190232843 @default.
• W1497014525 hasConcept C202751555 @default.
• W1497014525 hasConcept C207001950 @default.
• W1497014525 hasConcept C2776194525 @default.

• next